Time dependency of hematopoietic growth factor coupled to chronotoxicity of carboplatin

Ilan G. Ron, Leah Peleg, Shlomit Rienstein, Aviva Dotan, Aharon Ticher, Svetlana Wolfson, Israel E. Ashkenazi

Research output: Contribution to journalArticlepeer-review

Abstract

A growing body of data suggests that cancer therapy may be improved and toxicity reduced by administration of antineoplastic agents and cytokines at carefully selected times of the day. The time-dependent effects of each of the drugs have been documented, but not their mutual time dependencies. In the present studies we sought to determine the best time for granulocyte colony-stimulating factor (G-CSF) administration after carboplatin treatment. Carboplatin was injected in different groups of ICR mice at four different circadian stages for 5 consecutive days. Mice were synchronized with an alternation of 12 h of light (from 6:00 a.m. to 6:00 p.m.) and 12 h of darkness. After the last injection, peripheral WBCs of three mice from each group were counted every 4 h over a 24-h period. Bone marrow toxicity was estimated with the mean 24-h WBC count. The most severe leukopenia occurred in the group injected at 3:00 p.m. - 9 h after light onset. The second set of experiments evaluated the time-dependent effect of G-CSF when singly injected or given after carboplatin injections for 5 days only at 3:00 p.m. G-CSF was injected into various groups on days 8 and 9 at the same four different circadian stages. On the 10th day after the first injection, peripheral WBCs of three mice from each group were counted every 4 h over a 24-h period. Time-dependent effects were observed when G-CSF was injected as a single agent. When G-CSF was given at various times to the group with the most severe carboplatin-induced leukopenia, peripheral WBC count recovery was monitored at all injection times; it reached its highest level (exceeding even that of the control) when G-CSF was injected at 3:00 a.m. Dosing times of both chemotherapy and growth factor are relevant for optimization of carboplatin's hematologic tolerability.

Original languageEnglish
Pages (from-to)135-141
Number of pages7
JournalCancer Chemotherapy and Pharmacology
Volume42
Issue number2
DOIs
StatePublished - 1998

Keywords

  • Carboplatin
  • Chronotoxicity
  • G-CSF

Fingerprint

Dive into the research topics of 'Time dependency of hematopoietic growth factor coupled to chronotoxicity of carboplatin'. Together they form a unique fingerprint.

Cite this